Colgate-Palmolive Company (CL)
Last Price$92.81.8%
Market Cap$75.3B
CL Rating
CL Quality rating performance
CL Intrinsic Value
Key Highlights:
As of Mar 03, 2025 CL Relative Value is $87.1, which is overvalued by 6.1%, compared to current share price of $92.8.
As of Mar 03, 2025 CL DCF Value is $77.4, which is overvalued by 16.6%, compared to current share price of $92.8.
CL Share Price History
1W 3.0%
1M 6.6%
6M (13.5%)
YTD 17.5%
1Y 8.6%
3Y 28.1%
5Y 44.5%
10Y 64.9%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
CL Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$75.3B
$82.7B
$20.1B
$3,546.0M
Shares Outstanding
811M
Employees
34K
Growth (CAGR)
5.1%
(0.96%)
7.13%
Profitability
60.5%
22.1%
14.4%
20.4%
17.6%
119.5%
Intrinsic Value
$83.3 (10.2% overvalued)
$79.2
$87.5
65.4%
Return on Capital
Financial Health
$1,096.0M
$7,416.0M
2.1x
25.5x
1,564.7%
Dividends
5.5%
2.4%
50.5%
Jan 21, 2025
Earnings
Apr 24, 2025
BEAT by 0.5%
BEAT by 2.2%
9 Beat & 1 Miss
CL Stock Financials
CL Income Statement Metrics
Annual
Quarterly
LTM
CL Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$4,107.0M +9.7% YoY
Capital Expenditure (CAPEX)
($561.0M) -20.4% YoY
Free Cash Flow (FCF)
$3,546.0M +16.6% YoY
CL Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$20.1B 3.3% YoY
Cost of revenue
$7,940.0M (2.3%) YoY
Pre-tax income
$3,956.0M 16.6% YoY
19.7% margin
CL Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$16.0B
Current assets ($5,317.0M, 33.1% of total)
$1,096.0M (6.8%)
$1,521.0M (9.5%)
Other current assets
$2,700.0M (16.8%)
Non-current assets ($10.7B, 66.9% of total)
$0.0 (0.0%)
$4,422.0M (27.6%)
$1,756.0M (10.9%)
Other non-current assets
$4,551.0M (28.4%)
Financial position
$6,193.0M
Cash & Short-term
Investments
Total Debt
CL Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
CL Earnings Surprises
Crunching data... Almost there!
CL Dividends
CL Dividend Yield
Crunching data... Almost there!
CL Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with CL
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$75.3B | 7.0 | $83.3 10.2% overvalued | 8.6% | $20.1B | $3,546.0M | 3.3% | 17.6% | 60.5% | 30.9% | 1,564.7% | |
$411.8B | 7.1 | $135.9 22.6% overvalued | 12.1% | $84.3B | $16.7B | 0.5% | 19.8% | 51.3% | 19.2% | 67.4% | |
$143.6B | 7.0 | $90.7 57.2% undervalued | 20.3% | €120.4B | €15.8B | 7.0% | 13.1% | 71.4% | 31.3% | 142.1% | |
$47.9B | 6.4 | $160.0 11.6% undervalued | 20.3% | $20.1B | $2,513.0M | (1.8%) | 12.5% | 35.8% | 28.9% | 705.1% | |
$45.5B | 5.8 | $21.1 11.3% overvalued | 29.2% | $15.5B | $1,335.0M | 0.1% | 8.6% | 57.9% | 10.1% | 90.2% | |
$27.1B | 6.3 | $79.8 28.8% overvalued | 11.9% | $6,107.1M | $976.4M | 4.1% | 16.0% | 45.2% | 8.9% | 41.1% | |
$25.7B | 5.0 | $93.6 33.4% undervalued | (51.7%) | $15.2B | $1,145.0M | 0.1% | 7.6% | 73.1% | 0.2% | 225.1% | |
$19.3B | 6.6 | $117.2 24.8% overvalued | 5.0% | $7,165.0M | $695.0M | (2.0%) | 9.7% | 44.5% | 38.2% | 2,555.4% | |
$9,261.6M | 7.3 | $22.2 45.4% overvalued | 176.7% | $1,476.5M | $198.3M | 69.3% | 13.4% | 76.6% | 55.5% | 2.4% | |
$4,901.6M | 5.1 | $15.4 182.3% undervalued | (56.1%) | $6,090.4M | $293.5M | 1.3% | 4.8% | 64.6% | 7.0% | 7.8% | |
$3,814.9M | 6.1 | $64.1 0.4% undervalued | (69.5%) | $1,302.0M | $24.6M | 46.3% | 1.9% | 71.1% | 15.2% | 39.4% |
FAQ
What is Colgate-Palmolive Company (CL) stock rating?
As of today, Colgate-Palmolive Company has a stock rating of 7 (out of 10), which is considered Good.
is Colgate-Palmolive Company (CL) a good stock to buy?
As of today, Colgate-Palmolive Company has a Good stock rating, which is 10.2% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.